Literature DB >> 7805878

Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2.

G P Shi1, H A Chapman, S M Bhairi, C DeLeeuw, V Y Reddy, S J Weiss.   

Abstract

A 1670-bp cDNA coding for a novel human cysteine protease has been isolated from a monocyte-derived macrophage cDNA library. This cDNA predicts a 329-amino acid preprocathepsin with more than 50% identity to both human cathepsin S and cathepsin L and 94% identity to a rabbit cDNA, termed OC2, recently isolated from osteoclasts. Based on its high homology to OC2, we have named the human enzyme cathepsin O. Cathepsin O mRNA was identified as a single approximately 1.7 kb transcript in cultures of 15-day-old monocyte-derived macrophages, but was not expressed in human monocytes or alveolar macrophages. When transfected into COS-7 cells, cathepsin O displayed potent endoprotease activity against fibrinogen at acid pH. This novel endoprotease may play an important role in extracellular matrix degradation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7805878     DOI: 10.1016/0014-5793(94)01349-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis.

Authors:  W S Hou; D Brömme; Y Zhao; E Mehler; C Dushey; H Weinstein; C S Miranda; C Fraga; F Greig; J Carey; D L Rimoin; R J Desnick; B D Gelb
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

2.  High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K.

Authors:  A F Schilling; C Mülhausen; W Lehmann; R Santer; T Schinke; J M Rueger; M Amling
Journal:  Osteoporos Int       Date:  2007-01-06       Impact factor: 4.507

Review 3.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

Review 4.  Molecular aspects of osteoclast function.

Authors:  T J Hall; T J Chambers
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

Review 5.  Cysteinyl cathepsins in cardiovascular diseases.

Authors:  Xian Zhang; Songyuan Luo; Minjie Wang; Guo-Ping Shi
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2020-01-09       Impact factor: 3.036

6.  A preliminary gene map for the Van der Woude syndrome critical region derived from 900 kb of genomic sequence at 1q32-q41.

Authors:  B C Schutte; B C Bjork; K B Coppage; M I Malik; S G Gregory; D J Scott; L M Brentzell; Y Watanabe; M J Dixon; J C Murray
Journal:  Genome Res       Date:  2000-01       Impact factor: 9.043

7.  Manipulating substrate and pH in zymography protocols selectively distinguishes cathepsins K, L, S, and V activity in cells and tissues.

Authors:  Catera L Wilder; Keon-Young Park; Philip M Keegan; Manu O Platt
Journal:  Arch Biochem Biophys       Date:  2011-09-29       Impact factor: 4.013

8.  Novel pycnodysostosis mouse model uncovers cathepsin K function as a potential regulator of osteoclast apoptosis and senescence.

Authors:  Wei Chen; Shuying Yang; Yoke Abe; Ming Li; Yucheng Wang; Jianzhong Shao; En Li; Yi-Ping Li
Journal:  Hum Mol Genet       Date:  2007-01-08       Impact factor: 6.150

9.  Cystatin C deficiency in human atherosclerosis and aortic aneurysms.

Authors:  G P Shi; G K Sukhova; A Grubb; A Ducharme; L H Rhode; R T Lee; P M Ridker; P Libby; H A Chapman
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

10.  Cathepsin K Deficiency Ameliorates Systemic Lupus Erythematosus-like Manifestations in Faslpr Mice.

Authors:  Yi Zhou; Huimei Chen; Li Liu; Xueqing Yu; Galina K Sukhova; Min Yang; Vasileios C Kyttaris; Isaac E Stillman; Bruce Gelb; Peter Libby; George C Tsokos; Guo-Ping Shi
Journal:  J Immunol       Date:  2017-01-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.